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AbstrACt
Objective Predictive statistical models used in 
population stratification programmes are complex 
and usually difficult to interpret for primary care 
professionals. We designed FINGER (Forming and 
Identifying New Groups of Expected Risks), a new 
model based on clinical criteria, easy to understand 
and implement by physicians. Our aim was to assess 
the ability of FINGER to predict costs and correctly 
identify patients with high resource use in the following 
year.
Design Cross-sectional study with a 2-year follow-up.
setting The Basque National Health System.
Participants All the residents in the Basque Country 
(Spain) ≥14 years of age covered by the public healthcare 
service (n=1 946 884).
Methods We developed an algorithm classifying 
diagnoses of long-term health problems into 27 chronic 
disease groups. The database was randomly divided 
into two data sets. With the calibration sample, we 
calculated a score for each chronic disease group 
and other variables (age, sex, inpatient admissions, 
emergency department visits and chronic dialysis). 
Each individual obtained a FINGER score for the year 
by summing their characteristics’ scores. With the 
validation sample, we constructed regression models 
with the FINGER score for the first 12 months as the 
only explanatory variable.
results The annual FINGER scores obtained by patients 
ranged from 0 to 57 points, with a mean of 2.06. 
The coefficient of determination for healthcare costs 
was 0.188 and the area under the receiver operating 
characteristic curve was 0.838 for identifying patients 
with high costs (>95th percentile); 0.875 for extremely 
high costs (>99th percentile); 0.802 for unscheduled 
admissions; 0.861 for prolonged hospitalisation (>15 
days); and 0.896 for death.
Conclusion FINGER presents a predictive power for 
high risks fairly close to other classification systems. Its 
simple and transparent architecture allows for immediate 
calculation by clinicians. Being easy to interpret, it might 
be considered for implementation in regions involved in 
population stratification programmes.
IntrODuCtIOn 
In recent decades, the type of patients served 
by healthcare organisations has evolved. Life 
expectancy increases, the development of 
more effective treatments or variations in life-
styles have contributed to change the profile 
of health problems.1 Currently, chronic 
diseases and multimorbidity (ie, the simulta-
neous presence of several health problems in 
the same person) represent the most preva-
lent epidemiological pattern at the popula-
tion level.2–4 
Caring for chronic illnesses and for patients 
with complex needs is challenging.5 The 
healthcare provided to such patients is often 
poorly coordinated, and this has a negative 
impact on quality of care and increases health-
care costs.5–7 Furthermore, a small number 
strengths and limitations of this study
 ► We propose a new population stratification sys-
tem to identify high-risk patients based on clinical 
criteria.
 ► We analysed data for an entire healthcare system, 
providing near universal care for the population of 
a defined geographical area and integrating data 
from primary healthcare, hospitals and outpatient 
specialised care.
 ► In the search of becoming a tool for real-world im-
plementation, our system only contains variables 
routinely recorded in electronic health records for 
all patients (ie, diagnoses, demographics, previous 
inpatient admissions and emergency department 
visits).
 ► For such reason, relevant factors for which there 
is not usually consistent information in medical re-
cords and administrative databases (psychosocial 
and socioeconomic variables; lifestyle and risk be-
haviours; self-perceived health) were not taken into 
account.
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of patients with multimorbidity require so many repeat 
admissions to hospital and other costly treatments that 
the associated costs absorb most of the budget of health-
care organisations.8 Because individuals have different 
levels of morbidity, they require different types of health-
care. Hence, a health organisation needs to provide the 
right care to the right patient to be successful. Examples 
of those designs are the Chronic Care Model9 10 or the 
Kaiser Permanente Pyramid Model.11
One of the main challenges in matching health provi-
sion to need is the development of information systems 
able to identify groups of patients with similar level of 
morbidity, risk of impairment and healthcare needs.12 
The establishment of homogeneous groups of patients 
is the starting point of risk adjustment systems.13–15 
Such systems were originally developed in the USA. 
Their initial purpose was for managing funding and 
contracting of services, although they have other applica-
tions such as for fair comparisons of the performance of 
providers and population stratification. Risk adjustment 
models require access to explanatory variables (data on 
clinical and demographic characteristics, or previous 
healthcare costs) for the entire population. They use 
statistical models, and provide predictions regarding 
future healthcare resource use, hospitalisation or other 
variables of interest.16 17 Nowadays, the use of risk adjust-
ment is diverse. In the USA, it is a fundamental tool in 
the financing of federal health insurance programmes as 
Medicare. Risk adjustment is also used for the reimburse-
ment to health insurance carriers in countries with health 
insurance system such as the Netherlands, Germany, Swit-
zerland or Belgium.18
However, there are other countries where the use of 
risk adjustment is rare. Spain, with a National Health 
System characterised by public financing and a high 
proportion of public provision, is one of them, although 
different studies confirm the benefits derived from this 
methodology19–21 The main barrier explaining the lack of 
use of risk adjustment in Spain is lack of acceptance by 
clinicians. They tend not to trust such complex statistical 
models because they find them difficult to interpret.22 As 
a result, in many countries23 including Spain,24 the iden-
tification of high-risk populations is provided by both 
risk scores from statistical models and judgements from 
clinicians. Such double routes for recruitment produces 
misunderstanding in physicians, results in inclusion in 
programmes of patients with heterogeneous needs and 
hampers the evaluation of interventions.
This paper proposes a new population stratification 
system that balances the tradeoff between predictability 
and simplicity. We sacrifice predictive power so as to gain 
in simplicity and acceptance. Our proposal therefore is 
not presented as a reimbursement system for insurance 
carriers. It is based on clinical criteria, and is easy for 
healthcare professionals to understand and apply. We 
called this system FINGER (Forming and Identifying New 
Groups of Expected Risk, or from the Spanish, Formación 
e Identificación de Nuevos Grupos de Estratificación de Riesgo) 
because it points to high-risk patients and can be calcu-
lated immediately by health professionals following 
some simple rules with the information of the presence 
of chronic conditions. The objective of this study is to 
assess the validity of statistical models based on FINGER 
to predict healthcare resources use, and determine its 
ability to prospectively identify individuals at high risk of 
hospitalisation or health costs.
MethODs
Data
This is a cross-sectional study. All individuals covered by 
the Basque public health system on 1 September 2008 
comprise our population. However, we excluded the 
paediatric population (individuals under 14 years old) 
because our main focus is the design of a risk stratifica-
tion model based on the presence of chronic conditions 
and our goal is to identify people with the greatest health-
care needs. A total of 28 151 people did not complete the 
second follow-up year due to death (n=18 547), transfer or 
other causes (n=9604). Those citizens in the study popu-
lation who died during the second year were included, 
whereas those who withdrew for other reasons were not. 
Hence, our total sample consists of 1 946 884 individuals.
The study period corresponds to two consecutive 
12-month intervals. First year data (1 September 2007–31 
August 2008) establish the explanatory variables. Second 
year data (1 September 2008–31 August 2009) validate 
our estimations.
Data were retrieved from the different available sources 
of information: primary care electronic health records, the 
minimum basic data set from hospital discharge reports 
and electronic records from day hospitals and from visits 
to emergency departments and specialised care. This way, 
we obtain demographic (age and sex) and clinical infor-
mation (International Classification of Diseases, Ninth 
Revision, Clinical Modification (ICD-9-CM) codes for the 
diagnoses made), as well as the history of all contacts that 
our population had with the different levels of provision 
at the health system, and their healthcare costs. The data-
base used has been described in more detail in previous 
publications.25
Patient and public involvement
Patients and public were not involved in this study.
Patient classification
FINGER is a patient classification system that provides 
an individual risk for each person. We first collapsed all 
ICD-9-CM codes of chronic pathologies into 27 chronic 
disease groups (CDGs) (table 1). Then we assigned one 
relative weight to every CDG, based on our linear regres-
sion estimations for healthcare cost in the following year, 
setting a maximum score of 10 for a CDG. Each patient 
obtained his chronic morbidity score by adding the scores 
of all diagnosed CDGs. For each patient, any given CDG 
did not count more than once; that is, multiple diagnoses 
 o
n
 14 January 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-019830 on 31 May 2018. Downloaded from 
3Orueta JF, et al. BMJ Open 2018;8:e019830. doi:10.1136/bmjopen-2017-019830
Open Access
corresponding to the same CDG did not change an indi-
vidual’s score. Likewise, we added weights for age groups, 
sex and previous hospital utilisation to obtain the final 
score for each patient also based on our linear regression 
estimations (table 2). A more complete description of 
FINGER and its design is included in the  online supple-
mentary appendix.
study variables and statistical models
To avoid overadjustment problems, we randomly divided 
the database into two subsets: the first for designing and 
calibrating the FINGER system, and the second exclu-
sively for validation. A comparison of the characteristics 
of both subpopulations of patients are included in the 
Table 1 Distribution of the population of the Basque 
Country across chronic disease groups (CDGs)*
CDGs Patients (N) %
Infectious and parasitic diseases 5133 0.26
Malignant neoplasms 33 569 1.72
Other endocrine disorders 57 862 2.97
Diabetes mellitus 84 697 4.35
Hyperlipidaemia 143 184 7.35
Diseases of the blood and blood-
forming organs
9189 0.47
Diseases of the nervous system 41 153 2.11
Diseases of the sense organs 66 277 3.40
Other heart diseases 21 755 1.12
Hypertension 197 693 10.15
Congestive heart failure 11 376 0.58
Stroke 20 216 1.04
Other vascular diseases 14 642 0.75
Other respiratory diseases 3239 0.17
Chronic obstructive pulmonary 
disease
29 154 1.50
Asthma 44 080 2.26
Diseases of the digestive system 39 764 2.04
Diseases of the genitourinary system 87 665 4.50
Diseases of the skin and 
subcutaneous tissue
20 131 1.03
Diseases of the musculoskeletal 
system
110 494 5.68
Congenital anomalies 13 794 0.71
Other mental illnesses 124 407 6.39
Alcohol and substance abuse 11 138 0.57
Schizophrenia and psychosis 9631 0.49
Metastasis 2668 0.14
Obesity 19 503 1.00
Other miscellaneous conditions 12 019 0.62
*An individual may be included in several groups (except in the 
case of neoplasms and metastasis, when only the latter was 
considered).
Table 2 Score for chronic disease groups (CDGs), age 
groups, sex and previous hospital utilisation
Morbidity weights Weight
CDGs
  Metastasis 10
  Malignant neoplasms 4
  Congestive heart failure 4
  Chronic obstructive pulmonary disease 4
  Other vascular diseases 3
  Other heart diseases 3
  Diseases of the blood and blood-forming organs 2
  Diabetes mellitus 2
  Alcohol and substance abuse 2
  Stroke 2
  Schizophrenia and psychosis 2
  Diseases of the digestive system 1
  Hypertension 1
  Asthma 1
  Diseases of the nervous system 1
  Diseases of the sense organs 1
  Diseases of the musculoskeletal system 1
  Diseases of the skin and subcutaneous tissue 1
  Congenital anomalies 1
  Other mental illnesses 1
  Diseases of the genitourinary system 1
  Other endocrine disorders 1
  Other miscellaneous conditions 1
  Obesity 0
  Hyperlipidaemia 0
  Other respiratory diseases 0
  Infectious and parasitic diseases 0
Weights for other variables Weight
Age, years
  <45 0
  45–64 1
  65–74 2
  ≥75 3
Sex
  Male and ≥70 years old 1
Resource use previous year
  Hospital admissions (*)
   0 0
   1 2
   2 4
   3 8
   4+ 16
  Emergency department visits
   1+ 1
  Chronic dialysis
   Yes 10
*Excludes obstetric and traumatic conditions.
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online supplementary appendix (tables S1 and S2). With 
the validation sample, we estimated different regression 
models (linear and logistic) to obtain the risk scores for 
each individual. The dependent variable for the linear 
regression was healthcare costs of individuals in year 
2, while for logistic regressions, we used the following 
dependent variables also for year 2:
 ► High use of resources (belonging to the top 5% indi-
viduals with highest healthcare costs).
 ► Extremely high use of resources (belonging to the top 
1% individuals with highest healthcare costs).
 ► Emergency hospitalisations, excluding admissions 
for obstetric or traumatic conditions (since we aim 
to identify individuals who might benefit from case 
management programmes).
 ► Prolonged hospital stay (sum of hospital bed days 
for causes other than obstetric and traumatic condi-
tions >11 days).
 ► Very prolonged hospital stay (sum of hospital bed 
days for causes other than obstetric and traumatic 
conditions >15 days).
 ► Death.
The analyses were repeated four times. In each case, the 
only independent variable was the score that summed up 
the scores for the following sets of independent variables:
 ► Age and sex.
 ► Diagnoses (CDG categories).
 ► Age, sex and diagnoses combined.
 ► Age, sex, diagnoses and resource use combined.
To assess and compare the models, we calculate the 
coefficient of determination (R2) for linear regressions 
and the area under the receiver operating characteristic 
curve (AUC) for logistic regressions.
results
Descriptive statistics
The FINGER scores obtained by patients ranged between 
0 and 57, with a mean of 2.06. As expected, the distri-
bution was markedly skewed to the left: 33% of patients 
scored zero and 91% of patients scored no more than 
five points, while only 5% of patients obtained scores 
of 8 or more and just 1% obtained scores of 14 or more 
(figure 1).
The average healthcare expenditure on patients in the 
second year was €1126, ranging from €0 to €1 55 140. A 
total of 2 05 408 individuals (21.10%) incurred no health 
costs in this period, that is, they were non-users.
Regarding hospitalisations for causes other than obstetric 
and traumatic conditions in the 12 months of the study, 
3.48% of the population had at least one admission, while 
1.06% were admitted for at least 12 days and 0.73% for 
more than 15 days. Overall, 0.96% of patients died.
The number and percentages of patients that presented 
such events according to their FINGER scores are summed 
up in table 3.
Validation of the stratification system
The results of the linear regression analysis to predict 
resource use the year after patient classification are shown 
in table 4. The model using only the demographic variables 
explained 7% of the variability in healthcare costs while the 
model using only the chronic morbidity score based on the 
CDGs yielded an R2 of 0.143. The model combining the 
scores for the demographic variables and morbidity had a 
R2 of 0.155. Finally, the complete model, with the sum of 
the scores for the demographic variables, morbidity and 
previous resource use, yielded an R2 of 0.188.
Table 5 presents the results of logistic estimations 
predicting resource use, hospitalisation or death. Age and 
sex models presented AUC values between 0.74 and 0.79, 
while the most complete model combining demographic, 
morbidity and previous use information obtained AUC 
values always greater than 0.80, with particularly good 
results for identifying extreme cases: 0.88 for identifying 
top 1% individuals with highest healthcare costs and 0.86 
for individuals with length of stays at hospitals greater 
than 15 days. Regarding the prediction of death, using 
exclusively demographic variables produced notably 
good results (AUC=0.87), even better than only morbidity 
(AUC=0.78). However, combining demographic variables 
and morbidity or all these with previous resource use 
achieved AUC values close to 0.9.
DIsCussIOn
Main results and comparison with other predictive systems
This study describes the development and validation 
of a new population stratification system. Our model, 
FINGER, identifies individuals who will require a large 
amount of healthcare, or experience unexpected events 
such as emergency visits, hospitalisation or death. 
FINGER is easy to use and to understand and does not 
require complex statistical calculations, being exclusively 
based on data from health records. While age and sex 
predict 7% of the variability in future use of resources in 
the linear model, our morbidity score predicts 14% and 
the complete FINGER model predicts 19%. With respect 
Figure 1 Cumulative percentage of population according 
to their FINGER (Forming and Identifying New Groups of 
Expected Risks) score.
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to logistic models, we assess their ability to identify high-
risk individuals through the AUC. An AUC of 0.5 indi-
cates no predictive power at all (no better than chance). 
Differently, a value of 1 corresponds to optimal sensitivity 
and specificity. A model predictability is usually consid-
ered to be acceptable if AUC lies between 0.7 and 0.8, and 
good if it is above 0.8.26 Hence, FINGER has good power 
to prospectively identify individuals who will require a 
high or extreme resource use (0.838 and 0.875), emer-
gency hospital admission (0.802), prolonged hospitalisa-
tion (0.861) or those who will die (0.896). Comparing the 
results between the FINGER models, the addition of the 
previous resource use to a model based on age, sex and 
diagnoses only produced small differences. However, it is 
known that the AUC is harder to increase when the base-
line model performs well.27 In our case, we considered 
that such improvement, although modest, is worthwhile 
because the collection of such predictive variable does 
not involve difficulties.
A previous research25 used the same database to predict 
healthcare cost with highly sophisticated and recognised 
case-mix systems: Adjusted Clinical Groups (ACGs),28 
Clinical Risk Groups (CRGs)29 and Diagnostic Cost 
Groups (DCGs).30 They obtained coefficients of deter-
mination of 0.23, 0.22 and 0.25, respectively, with the 
best statistical models (including as explanatory variables 
prescriptions, previous healthcare cost percentile, age, 
sex and diagnoses). These results are also similar to those 
obtained by other authors, in other healthcare systems.31
Assessing the ability of models to identify high-risk indi-
viduals, the differences of FINGER with the above-men-
tioned case-mix systems are even smaller, although 
comparisons are partial. Due to restrictions in the use of 
databases and licensed software, it is only possible for us 
to access to published results.25 32 According to that, their 
AUC values ranged from 0.848 to 0.868 for high costs, 
0.869 to 0.899 for very high costs, 0.809 for hospitalisation 
and 0.870 for prolonged hospital stays.
This study employed data for an entire healthcare 
system, providing near-universal care for the population 
of a defined geographical area and integrating data from 
primary healthcare, hospitals and outpatient specialised 
care. However, our analyses are based on information 
registered some years ago. In this sense, the changes in 
clinical practice or health services management occurred 
in recent years could somehow affect the generalisation 
of the results to the present moment.
FINGER presents some limitations, some of which are 
common to other risk adjustment systems. First, some 
factors that are known to have impact on the need for 
healthcare or outcomes have not been included in the 
model; these include psychosocial and socioeconomic 
variables, as well as lifestyle and risk behaviours and 
self-perceived health.33 34 Usually, however, for most of 
such indicators, there is lack of consistent information 
in administrative databases at the present time.35 With 
the aim of developing a tool for real-world implementa-
tion, FINGER only contains variables routinely recorded 
in electronic health records for all patients. Second, to 
estimate the health status of individuals, FINGER only 
takes into account diseases and other health problems 
for which patients have demanded care from the public 
health system. Hence, unperceived needs could be not 
Table 4 Capacity of FINGER (Forming and Identifying New 
Groups of Expected Risks) to predict healthcare use in the 
year after patient classification
Independent variables R2
Age & sex 0.070
Diagnoses 0.143
Age & sex+diagnoses 0.155
Age & sex+diagnoses+resource use in 
previous year
0.188
Coefficients of determination (R2) from linear regression analysis.
Table 5 Results of the FINGER-based predictive models: area under the receiver operating characteristics curve (AUC) (CI 
95%)
FINGER scores 
(first year)
High costs
(>95th 
percentile)
Very high 
costs (>99th 
percentile) ≥1 admissions
Prolonged stay
(≥12 days)
Very prolonged 
stay (≥16 days) Death
N 48 734 9897 33 884 10 288 7072 9392
% 5.01 1.02 3.48 1.06 0.73 0.96
Age and sex 0.764
(0.762 to 0.766)
0.794
(0.79 to 0.798)
0.739
(0.736 to 0.742)
0.778
(0.773 to 0.782)
0.776
(0.771 to 0.782)
0.872
(0.869 to 0.875)
Diagnoses 0.772
(0.769 to 0.774)
0.807
(0.802 to 0.812)
0.733
(0.73 to 0.737)
0.785
(0.779 to 0.79)
0.796
(0.79 to 0.803)
0.782
(0.777 to 0.788)
Age & sex+diagnoses 0.826
(0.824 to 0.828)
0.866
(0.862 to 0.869)
0.789
(0.786 to 0.792)
0.844
(0.84 to 0.848)
0.851
(0.846 to 0.855)
0.898
(0.896 to 0.901)
Age 
and sex+diagnoses+
resource use in 
previous year
0.838
(0.836 to 0.84)
0.875
(0.872 to 0.879)
0.802
(0.799 to 0.805)
0.854
(0.85 to 0.858)
0.861
(0.857 to 0.866)
0.896
(0.893 to 0.899)
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taken into account. Further, although our health system 
provides almost universal coverage, some social groups 
may encounter barriers to access. Thirdly, it is known that 
the information recorded in electronic health records 
may be inaccurate.36 Additionally, FINGER classifies indi-
viduals’ health problems into only 27 disease groups, 
sometimes being difficult to identify patients with specific 
conditions. Finally, highly predictive variables such as 
previous healthcare cost37 38 were excluded because they 
are influenced by factors different to patient needs, such 
as the efficiency of healthcare provision.
Nevertheless, we attempted to provide the simplest 
algorithm so that family doctors may use the model 
as an assessment scale. Hence, we reduced FINGER 
to a reasonably small number of health problems, at 
the expense of getting a greater level of granularity. 
Notably, ACGs, CRGs and DCGs provide a great amount 
of information and describe the morbidity of a popula-
tion at a very disaggregated level, predicting somewhat 
better than FINGER in linear models and similarly well 
in logistic models. Since they detect health problems of 
individuals from their diagnoses and prescriptions, they 
overcome some of the limitations of using administrative 
databases.36 However, their classification algorithms are 
complicated and require the use of proprietary software. 
Often, the predictions are obtained from local calibration 
based on statistical regression models, and this model-
ling requires support from experts and it is beyond the 
abilities of clinicians. In most European health services, 
this process is only performed every several months,39 so 
there could be discrepancies between the present situa-
tion of the patient and his/her latest estimation of risk. In 
contrast, the open architecture of our FINGER system is 
very simple. It is based on fewer variables, and obtains the 
patient individual risk by a simple sum of scores. Hence, 
even if designed to classify the entire population of a 
given geographical area from administrative databases, 
its estimation may be performed or updated directly by 
family doctors during patient visits with data from health 
records without needing the use of any software.
Potential applications in healthcare systems
FINGER, as other case-mix systems, identifies patients 
who may be candidates for specific interventions. It 
discriminates particularly well individuals at high risk 
of future hospitalisation, prolonged hospital stays and 
extreme healthcare resource use. Hence, it allows clini-
cians to design specific programmes for certain diseases 
matching patients’ needs. Additionally, this system could 
also be used for other purposes, such as for describing the 
burden of morbidity and of certain health problems in 
populations in specific geographical areas.
The choice of a stratification model looks at both its 
predictive power and the level of granularity at which it 
describes population health needs. Nonetheless, other 
characteristics should also be considered. Currently 
used case-mix systems have demonstrated their statis-
tical validity in many countries and also in our setting. 
However, they are difficult to introduce in the context 
of a National Health System such as the Spanish, and in 
particular in the regional Basque Health System. They 
induce reluctance among primary care clinicians who 
do not see the clinical benefits of their use. Physicians 
demand a simpler model with transparent architecture, 
easy to calculate and interpret to overcome the barriers 
in its implementation.22 We understand FINGER fills this 
gap. We accept that it is not valid to be used for calculating 
reimbursement because it slightly sacrifices predictive 
power compared with other systems, but it still represents 
an attractive option for applying population stratification 
programmes in the context of a National Health System.
unanswered questions and future research
Nowadays, numerous efforts to transform models of 
health delivery are being implemented all over the 
world. A fundamental component of care management 
programmes is the targeting and selection of populations 
for such interventions. The new system for patient clas-
sification developed, FINGER, has shown to be able to 
predict healthcare costs and identify individuals who in 
the following 12 months will require a large amount of 
healthcare resources, need unscheduled admission to 
hospital or remain admitted for long periods of time, as 
well as be at risk of death. It has a straightforward design 
and is mainly based on the diagnoses of health prob-
lems for which patients have sought medical attention. 
We consider that it is intuitive, easy to understand and 
suitable for primary healthcare professionals. In relation 
to this, there is a need for future studies analysing the 
clinicians’ perceptions and opinions. Furthermore, our 
results should be tested in other settings or specific popu-
lation groups (eg, patients with multimorbidity or with 
specific diseases).
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